Real-time enrollment status for this papillary kidney cancer clinical trial
Current Status
Suspended
Checked: March 2, 2026 at 12:22 PM UTC
| NCT Number | NCT05411081 |
| Recruiting Status | Suspended |
| Condition | Papillary Kidney Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 200 participants |
| Active Locations | 199 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT05411081 is currently suspended participants. This clinical trial study for papillary kidney cancer is not currently accepting new participants at 199 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05411081 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 199 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05411081 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.